Jin Haijiao, Lv Shifan, Wang Ling, Zhang Minfang, Wang Qin, Fang Wei, Lin Xinghui, Che Xiajing, Yan Hao, Yu Zanzhe, Jiang Na, Li Zhenyuan, Che Miaoling, Ding Li, Huang Jiaying, Zhou Yin, Ni Zhaohui
Department of Nephrology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Clinical Research Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ther Apher Dial. 2023 Jun;27(3):464-470. doi: 10.1111/1744-9987.13943. Epub 2022 Nov 9.
Recent evidence suggests that automated peritoneal dialysis (APD) might be a feasible alternative to hemodialysis (HD) in urgent-start peritoneal dialysis.
This prospective study enrolled end-stage renal disease (ESRD) patients who had started APD as an urgent-start dialysis modality at a single center. Dialysis-related complications were recorded. Dialysis adequacy and electrolytes imbalance were compared between baseline, 14 and 42 days after catheter insertion. Technique survival and patient survival were also recorded.
A total of 36 patients were included in the study. Mean follow-up duration was 22 months. During the follow-up, 11 PD patients (30.6%) developed dialysis-related complications. Only two patients (5.6%) required re-insertion and one patients (2.8%) transfer to HD. The 2-year technique survival rate and patient survival rate were 94.4% and 97.2%, respectively.
In considering safety and dialysis adequacy, APD could be a feasible dialysis modality for urgent-start dialysis in ESRD patients, using a standard procedure.
最近的证据表明,在紧急启动腹膜透析中,自动化腹膜透析(APD)可能是血液透析(HD)的一种可行替代方法。
这项前瞻性研究纳入了在单一中心开始将APD作为紧急启动透析方式的终末期肾病(ESRD)患者。记录与透析相关的并发症。比较导管插入后基线、14天和42天的透析充分性和电解质失衡情况。还记录了技术生存率和患者生存率。
共有36例患者纳入研究。平均随访时间为22个月。随访期间,11例腹膜透析患者(30.6%)出现与透析相关的并发症。仅2例患者(5.6%)需要重新插管,1例患者(2.8%)转为血液透析。2年技术生存率和患者生存率分别为94.4%和97.2%。
考虑到安全性和透析充分性,使用标准程序时,APD可能是ESRD患者紧急启动透析的一种可行透析方式。